<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01320150</url>
  </required_header>
  <id_info>
    <org_study_id>WS735224</org_study_id>
    <nct_id>NCT01320150</nct_id>
  </id_info>
  <brief_title>Risk Factors and Mechanisms for Persistent Postsurgical Pain After Total Knee Replacement</brief_title>
  <acronym>PPP-TKA</acronym>
  <official_title>Risk Factors and Mechanisms for Persistent Postsurgical Pain After Total Knee Replacement</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rush University Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Pfizer</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Rush University Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Osteoarthritis (OA) is the single most common cause of disability in mid and late life. About
      27 million people in the United States suffer from this incurable process and 10 million have
      OA of the knee. Total knee replacement (TKR) is a reliable treatment option for patients
      disabled by knee OA who have failed non-operative treatment; 58% of these surgeries are
      performed on patients 65 years or older. Despite the overall success of TKR in most cases,
      persistent postsurgical pain (PPP) of the operated knee remains a common and often difficult
      to treat postoperative outcome affecting 13-20% of all patients at 6 months post-TKR, which
      amounts to 65,000-100,000 patients/year in the USA. Important secondary outcomes of PPP are
      restricted physical mobility and poor quality of life, especially in older patients.

      Recent findings spanning the pre-, intra- and postoperative periods suggest that the
      development of PPP after TKR is a multi-factorial process, comprised of both neurophysiologic
      and psychosocial factors. Likely determinates include preoperative thermal pain sensitivity,
      anxiety, pain catastrophizing; and postoperative area of secondary mechanical hyperalgesia or
      hypoalgesia (numbness). There is already agreement that the intensity of early (acute)
      postoperative pain is one of the factors predicting PPP. To date, most studies have examined
      the role of risk factors in isolation and/or within a single domain, and no prospective study
      has comprehensively evaluated the interaction of neurophysiologic and psychosocial variables
      in the evolution of PPP following TKR. The lack of information regarding how neurophysiologic
      pathways and patient cognitive/affective states interact over time following otherwise
      successful TKR has greatly undermined the understanding of PPP after TKR.

      The proposed project is a single-site, prospective study of 300 OA patients aged 18-85 yrs
      undergoing primary TKR. The study is designed to identify factors from the pre-, intra- and
      postoperative phases of TKR that contribute to PPP at 6 months. Specific risk factors were
      selected because they are potentially modifiable, and therefore may be amenable to
      intervention. Patients will be assessed from pre-surgery to 6 months post surgery. The
      proposed multi-factorial and prospective approach to investigating risk factors is a vital
      next step towards understanding the complex phenomenon of PPP.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Overall Strategy: The primary aim of this application is to investigate relationships of risk
      factors to the development of persistent postoperative pain (PPP) at 6 mo following TKR,
      through independently predictive and mediated models.

      These risk factors are preoperative thermal pain sensitivity, pain anxiety and
      catastrophizing; postoperative area of secondary mechanical hyperalgesia or hypoalgesia
      (numbness) and pain intensity. PPP for this study will be defined as &quot;pain in the operated
      knee at six months after TKR, with other causes of pain excluded and reported intensity on
      0-10 Numerical Response Scale (NRS) scale of ≥4&quot;. The study will also evaluate the
      relationship of PPP incidence with the severity of functional impairment. This is a
      single-site prospective clinical investigation of 300 consented OA patients undergoing
      primary, unilateral TKR.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2011</start_date>
  <completion_date type="Actual">April 2018</completion_date>
  <primary_completion_date type="Actual">August 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Subjects With Post-Operative Persistent Pain (PPP)</measure>
    <time_frame>6 months postoperatively</time_frame>
    <description>PPP for this study will be defined as &quot;pain in the operated knee at six months after Total Knee Replacement surgery, with other causes of pain excluded, and a reported intensity on 0-10 Numerical Response Scale (NRS) of ≥4 where higher pain scores indicate higher levels of pain. NRS scores range from 0 {No Pain} to 10 {Worst Imaginable Pain}.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">311</enrollment>
  <condition>Persistent Postsurgical Pain</condition>
  <arm_group>
    <arm_group_label>PPP and Non-PPP</arm_group_label>
    <description>Study Subjects with PPP and without PPP at followup</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      DNA, RNA
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Osteoarthritis patients at the RUSH university medical center undergoing primary,
        unilateral TKR
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  undergoing standard tricompartmental TKR;

          -  18 to 85 yrs of age;

          -  patient has a diagnosis of osteoarthritis

          -  knee to be replaced is the primary source of patient's pain;

          -  patient agrees to preoperative and follow-up visits and to comply with the assessment
             tests;

          -  patient consents to standard anesthetic and analgesic protocol, with medical care as
             deemed necessary by the anesthesiologist, and has no contraindications.

        Exclusion Criteria:

          -  chronic opioid use ≥ 10 mg/day of morphine equivalents within one wk prior to the
             surgery, and duration of use &gt; 4 wks;

          -  history of opioid abuse;

          -  inability to understand and communicate with the investigators to complete the study
             related questionnaires

          -  patient currently enrolled in another study;

          -  patient is planning to undergo another elective joint replacement procedure during the
             6-mo period of participation;

          -  any co-morbidity which results in severe systemic disease limiting function {as
             defined by the American Society of Anesthesiology (ASA) physical status classification
             &gt; 3}
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Asokumar Buvanendran, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rush University Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Rush University Medical Center</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60612</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2019</verification_date>
  <study_first_submitted>March 18, 2011</study_first_submitted>
  <study_first_submitted_qc>March 18, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 22, 2011</study_first_posted>
  <results_first_submitted>October 10, 2019</results_first_submitted>
  <results_first_submitted_qc>November 12, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">December 3, 2019</results_first_posted>
  <last_update_submitted>November 12, 2019</last_update_submitted>
  <last_update_submitted_qc>November 12, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">December 3, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Rush University Medical Center</investigator_affiliation>
    <investigator_full_name>Asokumar Buvanendran</investigator_full_name>
    <investigator_title>Attending Physician</investigator_title>
  </responsible_party>
  <keyword>persistent postsurgical pain (PPP)</keyword>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>August 1, 2017</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/50/NCT01320150/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>All Study Participants</title>
          <description>Study Subjects with and without Persistent Post-operative Pain (PPP) at followup</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="311"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>PPP</title>
              <participants_list>
                <participants group_id="P1" count="34"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Non-PPP</title>
              <participants_list>
                <participants group_id="P1" count="211"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="245"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="66"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Protocol Violation</title>
              <participants_list>
                <participants group_id="P1" count="15"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Death</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="44"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Persistent Post-surgical Pain (PPP) and Non-PPP groups are defined at 6 month follow-up.</population>
      <group_list>
        <group group_id="B1">
          <title>Non PPP</title>
          <description>Those without Persistent Post-surgical Pain (PPP)</description>
        </group>
        <group group_id="B2">
          <title>Persistent Post Surgical Pain (PPP)</title>
          <description>Those with Persistent Post-surgical Pain (PPP)</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="211"/>
            <count group_id="B2" value="34"/>
            <count group_id="B3" value="245"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="65" lower_limit="61" upper_limit="70"/>
                    <measurement group_id="B2" value="64" lower_limit="53" upper_limit="69"/>
                    <measurement group_id="B3" value="65" lower_limit="60" upper_limit="70"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="133"/>
                    <measurement group_id="B2" value="27"/>
                    <measurement group_id="B3" value="160"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="78"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="85"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>White</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="159"/>
                    <measurement group_id="B2" value="20"/>
                    <measurement group_id="B3" value="179"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>African American</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="52"/>
                    <measurement group_id="B2" value="14"/>
                    <measurement group_id="B3" value="66"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Subjects With Post-Operative Persistent Pain (PPP)</title>
        <description>PPP for this study will be defined as &quot;pain in the operated knee at six months after Total Knee Replacement surgery, with other causes of pain excluded, and a reported intensity on 0-10 Numerical Response Scale (NRS) of ≥4 where higher pain scores indicate higher levels of pain. NRS scores range from 0 {No Pain} to 10 {Worst Imaginable Pain}.</description>
        <time_frame>6 months postoperatively</time_frame>
        <group_list>
          <group group_id="O1">
            <title>PPP and Non-PPP</title>
            <description>Study Subjects with PPP and without PPP at followup</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Subjects With Post-Operative Persistent Pain (PPP)</title>
          <description>PPP for this study will be defined as &quot;pain in the operated knee at six months after Total Knee Replacement surgery, with other causes of pain excluded, and a reported intensity on 0-10 Numerical Response Scale (NRS) of ≥4 where higher pain scores indicate higher levels of pain. NRS scores range from 0 {No Pain} to 10 {Worst Imaginable Pain}.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="245"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>non PPP</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="211"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>PPP</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Subjects were followed for 6 months</time_frame>
      <desc>Subject were identified by group (PPP, non-PPP) at the end of the 6 month follow-up, so adverse events is based on one unified group.</desc>
      <group_list>
        <group group_id="E1">
          <title>All Study Participants</title>
          <description>Study Subjects with and without Persistent Post-operative Pain (PPP) at followup</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="311"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="311"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="311"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Robert McCarthy</name_or_title>
      <organization>Rush University Medical Center</organization>
      <phone>(312) 563-0448</phone>
      <email>Robert_J_McCarthy@rush.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

